Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia

NCT ID: NCT06818396

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-18

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is already known that fascia iliaca compartment block and intrathecal nalbuphine are very effective ways in postoperative pain control in patients having hip surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

US-guided fascia iliaca compartment block (FICB) and spinal anesthesia

Group Type ACTIVE_COMPARATOR

US-guided fascia iliaca compartment block (FICB) and spinal anesthesia

Intervention Type OTHER

US-guided fascia iliaca compartment block (FICB) and spinal anesthesia

Intrathecal nalbuphine and spinal anesthesia

Group Type ACTIVE_COMPARATOR

Intrathecal nalbuphine and spinal anesthesia

Intervention Type DRUG

intrathecal nalbuphine and spinal anesthesia

Spinal anesthesia

Group Type OTHER

Spinal anesthesia

Intervention Type OTHER

Spinal anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

US-guided fascia iliaca compartment block (FICB) and spinal anesthesia

US-guided fascia iliaca compartment block (FICB) and spinal anesthesia

Intervention Type OTHER

Intrathecal nalbuphine and spinal anesthesia

intrathecal nalbuphine and spinal anesthesia

Intervention Type DRUG

Spinal anesthesia

Spinal anesthesia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologists (ASA) score (ASA I- ASA II).
* Age ≥ 21years.
* Body mass index \< 35 kg/m2

Exclusion Criteria

* Patient's refusal.
* Known coagulopathy.
* Known peripheral neuropathy or neurological deficits.
* Known allergy to study drugs
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ibrahim Mamdouh Esmat

Professor of Anesthesia and Intensive Care,Faculty of Medicine, Ain- shams University, Cairo, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain-Shams University Hospitals

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ibrahim Mamdouh Esmat

Role: primary

01001241928

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU-MS 72 / 2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.